Search Results - Boring, D.L

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    225 Molecular targets of interest to the NCI PREVENT cancer preclinical drug development program

    225 Molecular targets of interest to the NCI PREVENT cancer preclinical drug development program by Shoemaker, R.H, Dunn, B.K, Suen, C, Lubet, R.A, Boring, D.L, Klein, B.D, Miller, M.S, Steele, V.E

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors : pharmacology of the carbonyl and ethanolamide groups

    Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors : pharmacology of the carbonyl and ethanolamide groups by BERGLUND, B. A, BORING, D. L, WILKEN, G. H, MAKRIYANNIS, A, HOWLETT, A. C

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors

    Cerebrodiene, arachidonylethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors by Boring, D.L., Berglund, B.A., Howlett, A.C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Structural requirements for arachidonylethanolamide interaction with CB 1 and CB 2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups

    Structural requirements for arachidonylethanolamide interaction with CB 1 and CB 2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups by Berglund, B.A., Boring, D.L., Wilken, G.H., Makriyannis, A., Howlett, A.C.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: